Journal of Cardiac Failure

Slides:

Advertisements

Similar presentations

A Comparison of Angiotensin Receptor-Neprilysin Inhibition (ARNI) With ACE Inhibition in the Long-Term Treatment of Chronic Heart Failure With a Reduced.

Advertisements

Update on PARADIGM-HF Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial John J.V.

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

Update on lichen planus and its clinical variants Gillian Weston, MSIII, Michael Payette, MD, MBA International Journal of Women's Dermatology Volume 1,

How surgeons can find information online? Martin Hewitt International Journal of Surgery Volume 5, Issue 6, Pages (December 2007) DOI: /j.ijsu

Update on PARADIGM-HF Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial John J.V.

Efficacy and Safety of Anti-thymocyte Globulin for the Treatment of Acute Cellular Rejection in Orthotopic Heart Transplant Stacy Crow, Samir J. Patel,

Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality—A retrospective.

Journal of Cardiac Failure

Influence of Diabetes on Cardiac Resynchronization Therapy With or Without Defibrillator in Patients With Advanced Heart Failure Jalal k. Ghali, MD,

Geriatric Inpatient Units in the Care of Hospitalized Frail Adults with a History of Heart Failure Shahyar Michael Gharacholou, Richard Sloane, Harvey.

Depressive Symptoms, Poor Nutritional Intake and Event-Free Survival in Patients with Heart Failure: A Deadly Chain of Events Eun Kyeung Song, Debra.

Intestinal Microbiota-Dependent Phosphatidylcholine Metabolites, Diastolic Dysfunction, and Adverse Clinical Outcomes in Chronic Systolic Heart Failure

Andrew Moran, MD, MPH, Ronit Katz, PhD, Nicolas L. Smith, PhD, Linda F

Yun Hyung Koog, Jin Su Lee, Hyungsun Wi

Determinants of Red Cell Distribution Width (RDW) in Cardiorenal Patients: RDW is Not Related to Erythropoietin Resistance Mireille E. Emans, MD, Karien.

Update on PARADIGM-HF Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial John J.V.

Journal of Cardiac Failure

Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials Gustavo Arruda Viani,

Differences in Mirnome, Transcriptome and Mitochondrial Function in 2 Mouse Models of Hypertrophic Cardiomyopathy Atprehypertrophic Stage Suggest Need.

Map the Gap: Regional Mapping to Assess Distribution of Heart Failure Mortality and Advanced Heart Failure Treatment Facilities Khansa Ahmad, Tisha Suboc,

Journal of Cardiac Failure

Volume 64, Issue 3, Pages (September 2014)

Journal of Cardiac Failure

Risk of Heart Failure in Obese Patients With and Without Bariatric Surgery in Sweden— A Registry-Based Study Christina E. Persson, MMed, Lena Björck,

The use of Intravenous Iron Therapy in Iron Deficient Patients with Heart Failure with Reduced Ejection Fraction: Decrease Hospitalizations and Improve.

Journal of Cardiac Failure

Site Selection and Performance in Clinical Trials

Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled.

Treating HFrEF: Challenges Faced

Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery S. Sabaté, A. Mases, N. Guilera, J.

Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD

N-terminal fragment of pro-B-type natriuretic peptide is a predictor of cardiac events in high-risk patients undergoing acute hip fracture surgery A.

Repeated Heart Rate Measurement and Cardiovascular Outcomes in Left Ventricular Systolic Dysfunction Victoria Hamill, PhD, Ian Ford, PhD, Kim Fox, MD,

In This Issue Cell Volume 158, Issue 5, (August 2014)

Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.

Adverse effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors associated with elevated serum IgE and eosinophilia Carol K. Fosso, MDa,

American Heart Association's Life's Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function Aaron R. Folsom, MD, Amil M. Shah,

The Impact of Prior Heart Failure Hospitalizations on Long-term Mortality Differs by Baseline Risk of Death Naga V.A. Kommuri, MD, Todd M. Koelling,

Redefining Appropriate Treatment Expectations

Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS

Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgery S. Farzi,

Volume 87, Issue 2, Pages (February 2015)

Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S

Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson

Erratum The American Journal of Human Genetics

Randomized clinical trial comparing endovenous laser ablation and stripping of the great saphenous vein with clinical and duplex outcome after 5 years

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Randomized trial comparing endovenous laser ablation of the great saphenous vein with high ligation and stripping in patients with varicose veins: Short-term.

Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study Victor Shi, Michele Senni, Hendrik.

Table of Contents Nurse Leader Volume 16, Issue 4, (August 2018)

Table of contents The Journal for Nurse Practitioners

Hospice Care for Heart Failure Patients

Psoas abscess in patients with an infected aortic aneurysm

Is age a predictor of mortality in a UK medical high dependency unit?

Reviewer Acknowledgment

C. J. Payne, S. C. Gibson, G. Bryce, A. G. Jardine, C. Berry, D. B

Table of contents The Journal for Nurse Practitioners

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

Journal of Investigative Dermatology

The future of cardiac surgery training: A survival guide

Journal of the American College of Surgeons

Effect of sacubitril/valsartan on the rate of heart failure (HF) hospitalisations as a time to first event analysis and as a recurrent event analysis of.

Michael S. Avidan, John P.A. Ioannidis, George A. Mashour

Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.

International Journal of Cardiology

Results of a single center vascular screening and education program

Eagle Syndrome Presenting After Blunt Trauma: A Case Series

Effect of sacubitril/valsartan on the rate of primary end point and component and all-cause mortality in patients randomised in the PARADIGM-HF trial according.

Presentation transcript:

Journal of Cardiac Failure Sacubitril/Valsartan Reduces Serum Uric Acid Level, an Independent Predictor of Adverse Outcomes in HFrEF: Results From PARADIGM-HF Ulrik M. Mogensen, Pardeep S. Jhund, Lars Køber, Margaret F. Prescott, Martin P. Lefkowitz, Jean-Lucien Rouleau, Scott D. Solomon, Karl Swedberg, Michael R. Zile, Milton Packer, John J.V. McMurray Journal of Cardiac Failure Volume 22, Issue 8, (August 2016) DOI: 10.1016/j.cardfail.2016.06.052 Copyright © 2016 Terms and Conditions

Fig Serum uric acid geometric means with 95% CI according to randomized treatment. *P < .001. Journal of Cardiac Failure 2016 22, DOI: (10.1016/j.cardfail.2016.06.052) Copyright © 2016 Terms and Conditions